Hospitalization Drug Regimen Changes in Geriatric Patients and Adherence to Modifications by General Practitioners in Primary Care

The Journal of Nutrition, Health & Aging
L RouchP Cestac

Abstract

To evaluate the overall rate of adherence by general practitioners (GPs) to treatment modifications suggested at discharge from hospital and to assess the way communication between secondary and primary care could be improved. Observational prospective cohort study. Patients hospitalized from the emergency department to the acute geriatric care unit of a university hospital. 206 subjects with a mean age of 85 years. Changes in drug regimen undertaken during hospitalization were collected with the associated justifications. Adherence at one month by GPs to treatment modifications was assessed as well as modifications implemented in primary care with their rationale in case of non-adherence. Community pharmacists' and GPs' opinions about quality of communication and information transfer at hospital-general practice interface were investigated. 5.5 ± 2.8 drug regimen changes were done per patient during hospitalization. The rate of adherence by GPs to treatment modifications suggested at discharge from hospital was 83%. In most cases, non-adherence by GPs to treatment modifications done during hospitalization was due to dosage adjustments, symptoms resolution but also worsening of symptoms. The last of which was particularly true ...Continue Reading

References

Jun 13, 2000·Pharmacy World & Science : PWS·K BrookesJ B McConnell
Apr 17, 2004·Pharmacy World & Science : PWS·Helen BolasJames McElnay
Jun 8, 2004·International Journal of Clinical Pharmacology and Therapeutics·W HimmelE Hummers-Pradier
Mar 2, 2005·Archives of Internal Medicine·Patricia L CornishEdward E Etchells
Sep 15, 2005·Archives of Internal Medicine·Eric A ColemanSung-joon Min
Apr 6, 2006·Quality & Safety in Health Care·T ViraE Etchells
Oct 27, 2006·Pharmacy World & Science : PWS·Benoît AllenetOrnella Conort
Apr 28, 2007·Clinics in Geriatric Medicine·Bryan D HayesFermin Barrueto
Jun 6, 2007·European Journal of Clinical Pharmacology·Thomas GrimmsmannWolfgang Himmel
Jun 8, 2007·European Journal of Clinical Pharmacology·Marie-Laure LarocheLouis Merle
Jan 26, 2008·International Journal of Clinical Pharmacology and Therapeutics·P GallagherD O'Mahony
Mar 3, 2011·Digestive Diseases and Sciences·Edward Sheen, George Triadafilopoulos
Mar 27, 2013·La Presse médicale·Jacques BlacherUNKNOWN Société française d’hypertension artérielle
Jul 3, 2013·International Journal of Clinical Pharmacy·Rachel UrbanJulie Morgan
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Philippe AutierPatrick Mullie
Oct 7, 2014·Journal of the American Medical Directors Association·Charlène CoolMaryse Lapeyre-Mestre
Feb 24, 2015·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·David B Hogan
May 15, 2015·European Journal of Clinical Pharmacology·Anna Renom-GuiterasPetra A Thürmann

❮ Previous
Next ❯

Citations

Apr 8, 2020·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Rachel DenholmRupert Payne
Apr 14, 2021·International Journal of Clinical Pharmacy·Lene Vestergaard Ravn-NielsenAnton Pottegård
Jul 11, 2021·The International Journal of Pharmacy Practice·Alexander SchützePeter Benöhr

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved